(UPDATE) Daratumumab
Update Carfilzomib Kyprolis
Elotuzumab
Selinexor
Teclistamab-cqyv
The Leukemia and Lymphoma Society
NCCN COVID-19 Resources Page
NCCN Virtual Reimbursement Resource Room
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic